MedTrace Logo

BETA: Study in Prediabetes Type 2 Diabetes

NCT07598773 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2026-05-20

No results posted yet for this study

Summary

This study is testing the feasibility of using non-invasive, remote digital tools including continuous glucose monitors (CGMs) and the Oura Ring to predict the function of beta-cells, the cells in the pancreas that secrete insulin. This study is being done in individuals with prediabetes or Type 2 diabetes. The aim is to develop remote digital tools that can predict the health and functioning of the pancreas in people with prediabetes or Type 2 diabetes, allowing personalized treatment approaches to preserve insulin secretion.

Conditions

Sponsors & Collaborators

  • Buck Institute for Research on Aging

    collaborator OTHER

  • Phenome Health

    collaborator UNKNOWN

  • AgileOps

    collaborator UNKNOWN

  • Oregon State University

    collaborator OTHER

  • 4YouandMe

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-25
Primary Completion
2027-02-01
Completion
2027-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07598773 on ClinicalTrials.gov